SCHEMBL9689099

SCHEMBL9689099

COc1c(C)cc(CCCCCCO)cc1C.CS(=O)(=O)O

nearest known ligand 0.42

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB4A known ✓ P04350 1/20 0.36
TUBB known ✓ P07437 1/20 0.36
TUBA3C known ✓ P0DPH7 1/20 0.36
TUBA1B known ✓ P68363 1/20 0.36
TUBA4A known ✓ P68366 1/20 0.36
TUBB4B known ✓ P68371 1/20 0.36
TUBB3 known ✓ Q13509 1/20 0.36
TUBB2A known ✓ Q13885 1/20 0.36
TUBB8 known ✓ Q3ZCM7 1/20 0.36
TUBA3E known ✓ Q6PEY2 1/20 0.36
TUBA1A known ✓ Q71U36 1/20 0.36
TUBA1C known ✓ Q9BQE3 1/20 0.36
TUBB6 known ✓ Q9BUF5 1/20 0.36
TUBB2B known ✓ Q9BVA1 1/20 0.36
TUBB1 known ✓ Q9H4B7 1/20 0.36
CYP4A11 Q02928 3/20 0.42
CYP4F2 P78329 2/20 0.42
NR3C1 P04150 1/20 0.41
NR3C2 P08235 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL10365500 0.98 CYP4A11 (0.41) CYP4A11CYP4F2NR3C1NR3C2LMNA
SCHEMBL9689627 0.89 TNKS2 (0.47) CYP4A11CYP4F2NR3C1NR3C2LMNA
SCHEMBL9689485 0.84 TNKS2 (0.53) CYP4A11CYP4F2NR3C1NR3C2HTR2B
SCHEMBL9689090 0.79 ALDH1A1 (0.46) NR3C1NR3C2LMNACA2ALDH1A1
SCHEMBL7933672 0.77 TNKS2 (0.41) CYP4A11CYP4F2CYP3A4MAPTMAPK1
SCHEMBL4166761 0.76 ALDH1A1 (0.42) CYP4A11CYP4F2NR3C1NR3C2MAPT
SCHEMBL20376310 0.74 TNKS2 (0.60) HTR2BTNKS2ALDH1A1TUBB4ATUBB
SCHEMBL6123748 0.74 TNKS2 (0.44) CYP4A11CYP4F2CYP3A4TDP1TNKS2
SCHEMBL4740186 0.74 TUBB4A (0.61) CYP3A4MAPTHTR2BCA2TNKS2
SCHEMBL6567714 0.74 TNKS2 (0.41) CYP4A11CYP4F2CYP3A4TNKS2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5120843-A Nervous system disorders UPJOHN (US) 1992-06-09 US disclosed
EP-0487510-A1 Pharmaceutically active amines THE UPJOHN COMPANY (US) 1992-05-27 EP disclosed
EP-0358676-A1 PHARMACEUTICALLY ACTIVE AMINES THE UPJOHN COMPANY (US) 1990-03-21 EP disclosed
EP-0293078-A1 Pharmaceutically active amines THE UPJOHN COMPANY (US) 1988-11-30 EP disclosed
WO-1988008424-A1 PHARMACEUTICALLY ACTIVE AMINES THE UPJOHN COMPANY (US) 1988-11-03 WO disclosed